HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
POCI
Precision Optics Corporation, Inc.
There isn't enough reported data to score POCI yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
POCI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
POCI's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
POCI PE Valuation
POCI has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
POCI Forward outlook
There aren't enough analyst estimates for POCI to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
POCI has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus POCI down 172%.
POCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2026 | -$0.64 | +$0.25 |
| Q4 2025 | -$0.93 | -$0.29 |
| Q3 2025 | -$0.85 | -$0.23 |
| Q2 2025 | -$0.85 | -$0.36 |
| Q1 2025 | -$0.89 | -$0.61 |
| Q4 2024 | -$0.64 | -$0.34 |
| Q3 2024 | -$0.62 | -$0.56 |
| Q2 2024 | -$0.49 | -2550% |
POCI lost $0.64 per share over the past year, a smaller loss than the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over POCI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
POCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | +42% |
| Q1 2026 | $8.7M | +108% |
| Q4 2025 | $7.4M | +63% |
| Q3 2025 | $6.7M | +59% |
| Q2 2025 | $6.2M | +31% |
| Q1 2025 | $4.2M | -20% |
| Q4 2024 | $4.5M | -6.2% |
| Q3 2024 | $4.2M | -2.9% |
POCI's revenue has grown year over year for five quarters in a row: $9M last quarter, up 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.2% | +21 points |
| Q1 2026 | -0.7% | +48 points |
| Q4 2025 | -24% | -3.5 points |
| Q3 2025 | -24% | +5.8 points |
| Q2 2025 | -22% | +6.8 points |
| Q1 2025 | -49% | -44 points |
| Q4 2024 | -20% | -5.5 points |
| Q3 2024 | -30% | -20 points |
POCI has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
POCI has the stronger cash trend. Its trailing FCF is down 5% versus its history, compared with HIMS at down 84%.
POCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$723.3K | +$1.3M |
| Q4 2025 | -$256.1K | +$560.6K |
| Q3 2025 | $78.2K | +$421.2K |
| Q2 2025 | -$615.5K | +$372.2K |
| Q1 2025 | -$2M | -$1.7M |
| Q4 2024 | -$816.6K | -$575.3K |
| Q3 2024 | -$343K | +$1.1M |
| Q2 2024 | -$987.6K | -$395.8K |
POCI has burned cash in most quarters: −$2M over the past year, against −$4M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over POCI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
POCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +79.5K shares |
| 1 year | +13% | +877K shares |
| 3 years | +38% | +2.2M shares |
| 5 years | +66% | +3.1M shares |
| Available history | +82% | +3.5M shares |
POCI has 8M diluted shares, up 13% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
POCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 4.6x | High |
POCI's net debt is about 4.6 years of its operating earnings (EBITDA).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
POCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.5 | Neutral |
| Stochastic | 69.4 | Neutral |
POCI's weekly RSI is 59 (neutral) and its Stochastic is 69 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
POCI PE vs Healthcare Sector
| Metric | POCI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
POCI has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
POCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.61 | 8.5% above |
| 20 week MA | $4.53 | 10% above |
| 50 week MA | $4.60 | 8.7% above |
| 100 week MA | $4.59 | 8.9% above |
| 200 week MA | $5.26 | 4.9% below |
POCI has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
POCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.40 | $4.20 | -22% |
| 2021 | $4.20 | $7.20 | +71% |
| 2022 | $7.20 | $5.55 | -23% |
| 2023 | $5.55 | $6.02 | +8.5% |
| 2024 | $6.02 | $5.01 | -17% |
| 2025 | $5.01 | $4.21 | -16% |
| 2026 YTD | $4.21 | $5.00 | +19% |
POCI has the edge over HIMS on returns for 2026, with the stronger performance.